- - .

Bicheng Zhang1, Lan Jin2, Dang Wu1

  • 1Department of Radiation Oncology, The Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, Zhejiang, China.

Frontiers in oncology
|September 24, 2025
PubMed
概括

患有固体瘤和骨髓干扰 (BMI) 的患者可以从积极的治疗中受益. 确定预后因素有助于选择可能对治疗反应良好的患者,改善生存结果.